The Rollins 7 Oxygen Mask is placed over the nose and mouth to administer oxygen and aerosol therapy via nebulizer only. The Rollins7 Oxygen Mask is for adult use only.

Device Description

The Rollins 7 Oxygen Mask consists of the following features: 1) mask, 2) strap holes, 3) swivel, 4) oxygen inlet, 5)oxygen inlet cap, 6) oxygen outlet diverter, 7) adapter body, 8) fenestration opening slits on both sides of the mask, 9) opening at the chin area, 10) MDI (metered dose inhaler) port hole inlet and insert locks in place, 11) adapter inlet bottom cap, 12) nebulizer inlet, 13) oxygen tubing, 14) oxygen mask inlet for connecting the adapter, and 15) design nipples (left and right) 16) oxygen tubing with one end universal connector and the other end standard oxygen connector 17) oxygen flow rate to FiO2 label attached to universal connector end.

AI/ML Overview

The Rollins 7 Oxygen Mask is a Class II medical device intended for administering oxygen and aerosol therapy via a nebulizer to adults. The device has been deemed substantially equivalent to the predicate device, Neb-U-Mask® (K080230), manufactured by Teleflex Medical, Inc. The evaluation did not involve human intervention in the device's performance, as no clinical tests were conducted.

1. Acceptance Criteria and Reported Device Performance

Acceptance Criteria	Reported Device Performance
Similar FIO2 delivery at various flow rates	Rollins7 Oxygen Mask delivers similar FIO2 at all settings.
Similar respirable particle dose delivery	Rollins7 Oxygen Mask had similar delivery of respirable particle dose compared to the predicate device for several highly used respiratory drugs.
Compliance with ISO 10993-5 (Cytotoxicity)	Demonstrated compliance with ISO 10993-5 Cytotoxicity Test Agar Diffusion.

2. Sample Size and Data Provenance

The study involved non-clinical testing only. There is no information regarding sample sizes for the test set or training set related to "data" in the context of human data.

The studies were conducted on the device itself and compared its performance to the predicate device.

3. Number of Experts and their Qualifications

Not applicable. No experts were used to establish ground truth for a test set, as no clinical studies were performed.

4. Adjudication Method

Not applicable. No adjudication method was used, as no clinical studies were performed.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No MRMC comparative effectiveness study was conducted, as the evaluation relied solely on non-clinical performance and comparative technical characteristics. There is no information on human readers or AI assistance.

6. Standalone Performance Study

Yes, a standalone performance study was done in the sense that the device's performance was evaluated independently through non-clinical laboratory testing. The device's ability to deliver oxygen and aerosol was assessed in a controlled environment without human interaction.

7. Type of Ground Truth Used

The ground truth used was established through objective laboratory measurements and comparisons to the predicate device's established performance.

FIO2 Delivery: Measurements of fractional inspired oxygen (FIO2) at various flow rates were compared against the predicate device.
Respirable Particle Dose Delivery: Cascade impactor studies were performed to measure and compare the respirable particle dose of common respiratory drugs aerosolized through the device versus the predicate device.
Biocompatibility: Compliance with ISO 10993-5 (Cytotoxicity) was assessed.

8. Sample Size for the Training Set

Not applicable. This device is a physical medical device, and the evaluation was based on non-clinical performance testing. No machine learning or AI models were used, thus no training set was involved.

9. How the Ground Truth for the Training Set was Established

Not applicable, as no training set was used.

Summary

{0}------------------------------------------------

510(k) Summary

Sponsor:	Rollins Medical Solutions, Inc.	807.92(a)(1)
Company Address:	1930 Village Center Circle PMB 3-314 Las Vegas, NV 89134
Telephone:	702-686-1803
Contact Person:	Michael Schlachter, MD	OCT 09 2013
Summary Preparation Date:	October 8, 2013
Device Name:		807.92(a)(2)
Trade Name:	Rollins 7 Oxygen Mask
Common/Usual Name:	Oxygen Mask
Classification Name:	Mask, Oxygen
Regulation Number:	21 CFR 868.5630
Product Code:	CAF
Device Classification:	Class II
Review Panel:	Anesthesiology

Predicate Device

and the country of the state of the same of the same of the secure ofManufacturer : " " " " " " "	. Brand Name	. 310 (k) Number 510(k) Number 100 (k)
Teleflex Medical, Inc.	Neb-U-Mask®	K080230

Device Description

{1}------------------------------------------------

Indications for Use

The Rollins7 Oxygen Mask is placed over the nose and mouth to administer oxygen and aerosol therapy via nebulizer only. The Rollins7 Oxygen Mask is for adult use only.

Contraindication: Rollins 7 Oxygen Mask should not be used with Metered Dose Inhalers.

Substantial Equivalent Comparison

807.92(a)(6)

Discussion of technical characteristics between the Rollins7 Oxygen Mask and the Predicate Oxygen Mask

A flow rate study was performed to ensure Rollins7 Oxygen mask provided the same FIO2 at various liters per minute settings as the predicate devices. The results demonstrated that the Rollins7 Oxygen mask delivers similar results at all settings.

Rollins 7 Oxygen Mask has a feature that allows for the use of a Naso-gastric tube, suctioning, oral care, endoscopies, and drinking through a straw by providing an opening in the chin area of the mask. This feature is fully describe in Section 11 11.2 and is a feature of convenience for the healthcare professional and does not in any way negatively affect its use as a simple oxygen mask or aerosol mask.

Comparative Non-Clinical Testing

Two cascade impactor studies were performed comparing the Rollins7 Oxygen Mask to the Hudson RCI Neb-U-Mask to ensure similar delivery of respirable particle dose for several highly used respiratory drugs. The results demonstrated that the Rollins7 Oxygen Mask had similar delivery of respirable particle dose of each drug tested as those of the predicate devices.

Performance Testing

807.92(b)(1)

ISO 10993-5 Cytotoxicity Test Agar Diffusion (Section 15) o
Flow Rate Testing (Section 18) .
Cascade Impactor Study Comparing the Adult Rollins7 Oxygen Mask and Predicate Mask . from Hudson RCI on a Human Model

Clinical Testing

807.92(b)(2)

No clinical tests were conducted.

{2}------------------------------------------------

807.92(b)(3)

Conclusions

Based on the predicate product comparison table of similar indications for use, product features, performance claims, discussion of the technological differences of the Rollins7 Oxygen Mask versus the predicate masks and the results of flow rate testing and cascade impactor studies Rollins Medical Solutions has concluded that the Rollins7 Oxygen Mask is substantially equivalent to the predicate devices and introduces no new issues of safety and effectiveness.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle or bird-like symbol with flowing lines, representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

October 9, 2013

Rollins Medical Solutions, Incorporated C/O Mr. EJ Smith Consultant Smith Associates 1468 Harwell Avenue CROFTON, MD 21114

Re: K130379

Trade/Device Name: Rollins7 Oxygen Mask Regulation Number: 21 CFR 868.5630 Regulation Name: Nebulizer Regulatory Class: II Product Code: CAF Dated: August 29, 2013 Received: September 6, 2013

Dear Mr. Smith:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Page 2 - Mr. Smith

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Image /page/4/Picture/6 description: The image shows a signature block. It includes the phrase "Sincerely yours," followed by the name "Tejashri Purohit-Sheth, M.D." and the title "Clinical Deputy Director." The acronym "DAGRID" is also present, along with the name "Kwame Ulmer M.S." and the word "FOR."

Kwame Ulmer M.S. Acting Division Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use

510(k) Number (if known): K130379

Device Name: Rollins7 Oxygen Mask

Indications for Use:

The Rollins 7 Oxygen Mask is placed over the nose and mouth to administer oxygen and aerosol therapy via nebulizer only. The Rollins7 Oxygen Mask is for adult use only.

Prescription Use _ X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Anya C
-S

y
Digitally signed by Anya C. Harry -S
DN: C=US, O=U.S. Government, ou=HHS,
ou=FDA, ou=People, cn=Anya C. Harry -S,
0.9.2342.19200300.100.1.1=0011315590
Date: 2013.10.09 08:47:44 -04'00'

Page 1 of _l

Regulation Number and Section

§ 868.5630 Nebulizer.

(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).